UB Paderborn / Katalog / Suche / in CDI

Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.

1 – 25 von 66

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

The New England journal of medicine, 2011-10, Vol.365 (16), p.1482-1491

2011

Volltextzugriff (PDF)

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

The Lancet infectious diseases, 2012-04, Vol.12 (4), p.307-317

2012

Volltextzugriff (PDF)

Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial

The Lancet (British edition), 2010-07, Vol.376 (9734), p.33-40

2010

Volltextzugriff (PDF)

Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir

AIDS (London), 2011-08, Vol.25 (13), p.1603-1609

2011

Volltextzugriff (PDF)

Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa

PloS one, 2016-08, Vol.11 (8), p.e0161469-e0161469

2016

Volltextzugriff (PDF)

Giant bacillary angiomatosis

Southern African journal of HIV medicine, 2021, Vol.22 (1), p.1257-1257

2021

Volltextzugriff (PDF)

Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study

Clinical infectious diseases, 2013-08, Vol.57 (4), p.586-593

2013

Volltextzugriff (PDF)

Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells

PloS one, 2016-07, Vol.11 (7), p.e0158262

2016

Volltextzugriff (PDF)

Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study

BMC infectious diseases, 2015-01, Vol.15 (1), p.12-12, Article 12

2015

Volltextzugriff (PDF)

The feasibility of using screening criteria to reduce clinic visits for stable patients on antiretroviral therapy in South Africa

Journal of acquired immune deficiency syndromes (1999), 2013-03, Vol.62 (3), p.e82-e86

2013

Volltextzugriff (PDF)

Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection

PloS one, 2014-02, Vol.9 (2), p.e89925-e89925

2014

Volltextzugriff (PDF)

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance

Scientific reports, 2018-10, Vol.8 (1), p.15751-7, Article 15751

2018

Volltextzugriff (PDF)

Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection

Journal of acquired immune deficiency syndromes (1999), 2011-11, Vol.58 (3), p.309-318

2011

Volltextzugriff (PDF)

Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa

AIDS research and therapy, 2018-04, Vol.15 (1), p.10-10, Article 10

2018

Volltextzugriff (PDF)

Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons : 2019 update

Southern African journal of HIV medicine, 2019, Vol.20 (1), p.1-16

2019

Volltextzugriff (PDF)

Infectious disease consultations at a South African academic hospital: A 6-month assessment of inpatient consultations

Southern African journal of infectious diseases, 2020, Vol.35 (1)

2020

Volltextzugriff (PDF)

Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial

PloS one, 2013-12, Vol.8 (12), p.e74900-e74900

2013

Volltextzugriff (PDF)

Reply to Gupta-Wright et al

Clinical infectious diseases, 2018-01, Vol.66 (1), p.159-159

2018

Volltextzugriff (PDF)

Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy; Results of 2 Phase II Multicenter Studies

Clinical infectious diseases, 2016-05, Vol.62 (9), p.1178-1185

2016

Volltextzugriff (PDF)

Maraviroc versus Efavirenz, Both in Combination with Zidovudine-Lamivudine, for the Treatment of Antiretroviral-Naive Subjects with CCR5-tropic HIV-1 Infection

The Journal of infectious diseases, 2010-03, Vol.201 (6), p.803-813

2010

Volltextzugriff (PDF)

Intensive adherence counselling for HIV‐infected individuals failing second‐line antiretroviral therapy in Johannesburg, South Africa

Tropical medicine & international health, 2016-09, Vol.21 (9), p.1131-1137

2016

Volltextzugriff (PDF)

Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus–Tuberculosis Coinfection

Clinical infectious diseases, 2021-08, Vol.73 (4), p.706-715

2021

Volltextzugriff (PDF)

Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus–Tuberculosis Coinfection

Clinical infectious diseases, 2021-02, Vol.73 (4), p.706-715

2021

Volltextzugriff (PDF)

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies

Clinical infectious diseases, 2012-06, Vol.54 (11), p.1660-1669

2012

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(66)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial

Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir

Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa

Giant bacillary angiomatosis

Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study

Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells

Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study

The feasibility of using screening criteria to reduce clinic visits for stable patients on antiretroviral therapy in South Africa

Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance

Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection

Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa

Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons : 2019 update

Infectious disease consultations at a South African academic hospital: A 6-month assessment of inpatient consultations

Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial

Reply to Gupta-Wright et al

Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy; Results of 2 Phase II Multicenter Studies

Maraviroc versus Efavirenz, Both in Combination with Zidovudine-Lamivudine, for the Treatment of Antiretroviral-Naive Subjects with CCR5-tropic HIV-1 Infection

Intensive adherence counselling for HIV‐infected individuals failing second‐line antiretroviral therapy in Johannesburg, South Africa

Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus–Tuberculosis Coinfection

Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus–Tuberculosis Coinfection

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies

Suchergebnisse filtern